Related Experiment Video
Updated: May 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study
Tamio Teramoto1, Ryuzo Kawamori, Shigeru Miyazaki
1Teikyo Academic Research Center , Itabashi-ku, Tokyo , Japan .
Insights
Identifying cardiovascular disease (CVD) risk factors in hypertensive patients is crucial. Statin therapy effectively prevents coronary heart disease (CHD) in patients with dyslipidemia, highlighting the importance of managing risk factors.
Area of Science:
- Cardiology
- Hypertension Management
- Preventive Medicine
Background:
- Hypertension is a major risk factor for cardiovascular disease (CVD).
- Identifying specific risk factors for CVD, stroke, and coronary heart disease (CHD) in hypertensive patients without prior CVD is essential for effective prevention strategies.
- The OMEGA study provided valuable data on this patient population.
Purpose of the Study:
- To identify risk factors for cardiovascular disease (CVD), stroke, and coronary heart disease (CHD) in hypertensive patients treated with antihypertensive drugs but without a history of CVD.
- To analyze the effect of statin therapy on CHD prevention in dyslipidemic patients within this cohort.
Main Methods:
- Analysis of subgroup data (n=13,052) from the prospective, observational Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement (OMEGA) study.
- Utilized a Cox proportional hazards model to examine risk factors for CVD, stroke, and CHD.
- Assessed the impact of baseline statin therapy on CHD prevention in dyslipidemic patients.
Main Results:
- Significant risk factors for CVD included older age, family history of CHD, diabetes, and current smoking. Female sex and social alcohol consumption were associated with lower risk.
- Diabetes was a risk factor for both stroke and CHD. Age, family history of CHD, and sodium intake score were specific risk factors for stroke.
- Sex, dyslipidemia, smoking, and exercise habits were specific risk factors for CHD. Statin therapy in dyslipidemic patients showed comparable CHD risk to non-dyslipidemic patients, while non-statin users had increased risk.
Conclusions:
- Risk factors for CHD and stroke differ in hypertensive patients treated with antihypertensive drugs and no prior CVD history.
- Managing dyslipidemia with statin therapy is crucial for the primary prevention of CHD.
- Effective hypertension therapy remains paramount for overall cardiovascular health.
Abstract:
To identify risk factors for cardiovascular disease (CVD) in hypertensive patients with no history of CVD being treated with antihypertensive drugs, we examined subgroup data (n = 13 052) from the prospective, observational Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement (OMEGA) study. Risk factors for CVD, stroke and coronary heart disease (CHD) were examined using a Cox proportional hazards model. In addition, the effect of statin therapy at baseline on CHD prevention was analyzed in dyslipidemic patients. The factors significantly related to CVD were female (hazard ratio [HR] = 0.637, 95% confidence interval [CI] 0.428-0.948), older age (65-69 years: HR = 2.165, 95% CI 1.214-3.861; 70-74 years: HR = 2.324, 95% CI 1.294-4.174; ≥75 years: HR = 2.448, 95% CI 1.309-4.578), family history of CHD (HR = 1.993, 95% CI 1.249-3.179), diabetes (HR = 2.287, 95% CI 1.700-3.078), current smoking (HR = 2.289, 95% CI 1.512-3.466) and alcohol drinking socially (HR = 0.589, 95% CI 0.379-0.913). Diabetes was a risk factor for both stroke and CHD, while age, family history of CHD, and sodium intake score were risk factors for stroke alone. Sex, dyslipidemia, smoking and exercise habits were risk factors for CHD alone. The risk of CHD in dyslipidemic patients on statin treatment was comparable to the risk in patients without dyslipidemia (HR = 1.134, 95% CI 0.604-2.126). However, in dyslipidemic patients not on statin treatment, the HR increased to 1.807 (95% CI 1.156-2.825). In conclusion, some risk factors for CVD in hypertensive patients being treated with antihypertensive drugs with no history of CVD differed between CHD and stroke. These results suggest the importance of managing dyslipidemia with a statin for primary prevention of CHD, as well as the importance of hypertension therapy.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents